RPT-Big Pharma beware: GSK China case may be just the beginning
May 18, 2014 at 17:00 PM EDT
SHANGHAI, May 18 (Reuters) - Chinese corruption charges against executives of British drugmaker GlaxoSmithKline Plc (GSK) could be just the start of the pharmaceutical industry's problems in its biggest emerging drugs market, according to industry sources in China.